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Abstract
Background: Health-related quality of life is recognized as a key outcome in chronic disease management,
including kidney disease. With no national healthcare coverage for hemodialysis, Ugandan patients struggle to pay
for their care, driving families and communities into poverty. Studies in developed countries show that patients on
hemodialysis may prioritize quality of life over survival time, but there is a dearth of information on this in
developing countries. We therefore measured the quality of life (QOL) and associated factors in end stage renal
disease (ESRD) patients in a major tertiary care hospital in Uganda.
Methods: Baseline QOL measurement in a longitudinal cohort study was undertaken using the Kidney Disease
Quality of Life Short Form Ver 1.3. Patients were recruited from the adult nephrology unit if aged > 18 years with an
estimated glomerular filtration rate ≤ 15mls/min/1,73m2. Clinical, demographic and micro-financial information was
collected to determine factors associated with QOL scores.
Results: Three hundred sixty-four patients (364) were recruited, of whom 124 were on hemodialysis (HD) and 240 on
non-hemodialysis (non-HD) management. Overall, 94.3% of participants scored less than 50 (maximum 100). Mean QOL
scores were low across all three principal domains: physical health (HD: 33.14, non-HD: 34.23), mental health (HD: 38.01,
non-HD: 38.02), and kidney disease (HD: 35.16, non-HD: 34.00). No statistically significant difference was found between
the overall quality of life scores of the two management groups. Breadwinner status (p < 0.001), source of income
(p0.026) and hemodialysis management type (p0.032) were the only factors significantly associated with QOL scores,
and this was observed in the physical health and kidney disease principal domains only. No factors were significantly
associated with scores for the mental health principal domain and/or overall QOL score.
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Conclusion: The quality of life of Ugandan patients with ESRD has been found to be lower across all three domains of
the Kidney Disease Quality of Life Short Form than reported anywhere in the world, with no difference observed
between the non-HD and HD management groups. Interventions targeting all domains of QOL are needed among
patients with ESRD in Uganda and, potentially, in other resource limited settings.
Keywords: Quality of life [MeSH], Kidney failure, Chronic [MeSH], Palliative care [MeSH], Renal Dialysis [MeSH],
Developing countries [MeSH], Resource limited setting, Low and middle income countries, LMIC
Background
The World Health Organization (WHO) defines quality
of life (QOL) as “an individual’s perception of their
position in life in the context of the culture and value
systems in which they live and in relation to their goals,
expectations, standards and concerns” [1]. In developed
world settings, various studies have demonstrated that
QOL is an independent predictor of both hospitalizations
and mortality [2–4]. Therefore slowing deterioration or
increasing quality of life has progressively become a key
outcome of successful disease management, including end
stage kidney disease (ESRD).
The global burden of kidney disease is increasing, with
incidence in the past three decades rising by 88% (11 to
21 million), prevalence by 87% (147 to 275 million),
death by 98% (0.6 to 1.2 million) and disability adjusted
life years by 62% [5]. The leading drivers for this have
been the global increase in non-communicable diseases,
particularly Diabetes Mellitus and Hypertension [5]. Re-
source-limited settings in Africa, Asia and Latin America
[5] face the greatest burden of the global increase in
chronic kidney disease (CKD) due to the double burden of
communicable and non-communicable disease. In these
settings, diarrheal diseases, malaria and HIV are additional
important contributors to chronic kidney disease burden
[6, 7]. In 2017, CKD caused more deaths globally than did
HIV or tuberculosis [8].
In contrast to epidemiological patterns observed in
resource-rich settings, chronic kidney disease incidence
in resource-limited settings peaks in adolescents and
young adults, further limiting economic productivity in
an environment which is already little equipped to
handle the disease [5]. Without medical management,
chronic kidney disease typically progresses to ESRD [9–11].
In resource-limited settings, poor health seeking behaviors
and lack of specialist care for renal disease mean that the
majority of patients present for the first time having already
developed ESRD [12, 13]. In Uganda, the prevalence of
chronic kidney disease has been found to vary from 0.7 to
21.4% in community studies [14, 15] while 51% of patients
attending a tertiary renal clinic had ESRD, with only 9% in
stage 1 CKD [16].
Worldwide, the quality of life of patients with ESRD is
typically poor [17, 18]. In resource-rich settings,
treatment for patients with ESRD includes hemodialysis
(HD), peritoneal dialysis and kidney transplantation [19].
These treatments, in addition to supportive care, such as
access to nutritional support, psychosocial supports,
spiritual support and optimal medical management of
co-morbidities, have been associated with an improved
quality of life [20]. In resource-limited settings such as
Uganda, where hemodialysis costs at least $400 USD/
month and renal transplantation is only available abroad
for a cost of at least $30,000 USD [21, 22], the majority
of patients with ESRD have no access to adequate
healthcare due to lack of health insurance or the
personal resources to pay for it.
With less than 20 Nephrologists serving a population
of over 45 million Ugandans and dialysis units in two
out of 134 districts in the country, the majority of pa-
tients have limited access to specialized care. Patients
who ultimately access HD often receive one or two
sessions per week, with very few managing a third ses-
sion due to the financial implications. Those who opt
for non-HD management receive a limited form of pal-
liative care from generalist care providers, lacking spir-
itual and psychosocial components but with an
emphasis on alleviation of symptoms and referral to
care providers closer to the patient’s home. Symptom
alleviation for these patients includes control of com-
plications of renal failure such as; volume overload
(treated by diuresis and volume restriction); uremic
syndrome (treated by intestinal dialysis with laxative
induced diarrhea); anemia (blood products and
erythropoietin stimulating agents); bone mineral dis-
ease (calcium replacement and phosphate binders)
and metabolic acidosis (oral bicarbonate replacement).
Comprehensive palliative care, however, involves far
more than symptom alleviation. It is an approach that
provides holistic (physical, psychosocial and spiritual)
management aimed at improving the health-related
quality of life of patients and families facing life-
threatening illness, such as ESRD [18, 23]. Although
palliative care services have been available in Uganda
since 1993, most of them are provided to cancer and
HIV/AIDS patients [24]. Yet ESRD patients in other
settings have been found both to have palliative care needs
[25] and to benefit from associated interventions [18].
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No studies have explored the quality of life or palliative
care needs of ESRD patients in Uganda. We undertook a
study among ESRD patients in Uganda on HD and non-
HD management to measure their quality of life and
explore the factors associated with it. The evidence we
generate will seek to inform the development of manage-
ment strategies that could best optimize the quality of life




This study represents baseline measurement in a longi-
tudinal cohort study of patients with ESRD attending
the adult nephrology unit of Mulago National Referral
Hospital. Data were collected between January and
November 2019. Mulago Hospital is a tertiary care
centre located in Kampala, Uganda, which houses the
largest renal unit in the country. Patients diagnosed with
renal failure from all parts of the country, including
neighbouring countries like the Democratic Republic of
Congo and South Sudan, are often seen in this unit,
which consists of a renal outpatient clinic, a renal
inpatient ward and an HD unit. Details of the broader
study can be found in the protocol paper [26].
Patient selection
Non-probability consecutive sampling was used to
recruit 364 participants using a proportion of 2:1 of
non-HD relative to HD patients. We chose this recruit-
ment design because of small overall patient numbers
and anecdotal evidence of high morbidity and mortality
amongst HD patients in particular. Recruitment was
carried out by two trained research assistants. The
sample size was calculated to achieve a study power of
80% with 95% confidence level for the comparison of
two means – HD vs non-HD, accounting for a high
attrition rate set at 30% [27]. To be eligible for participa-
tion in the study, patients had to be aged > 18 years with
documented evidence of ESRD defined as chronic kidney
disease stage V (estimated glomerular filtration rate of
15mls/min/1.73m2 or less calculated using Cockcroft-
Gault Formula). Patients with acute kidney injury
defined as an elevated serum creatinine for a period of
less than three months were not eligible for enrolment.
Data collection
Once patients had given written informed consent, a
four-part study questionnaire, pre-tested in a pilot study,
was administered to them by two research assistants.
The latter were trained (further details in protocol paper
[26]), observed while collecting data and found to be
capable of creating good rapport with patients and to
maintain neutrality while asking questions and filling in
patient responses. The pilot study had shown that
patient self-administration of the questionnaire resulted
into poor quality data.
Part 1 of the questionnaire collected sociodemographic
and financial information; Part 2 consisted of the Kidney
Disease Quality of Life-Short Form (KDQOL-SF) Ver-
sion 1.3 and collected quality of life information; Part 3
used The African Palliative Care Association Palliative
care Outcome Scale (APCA POS) to collect information
on palliative care needs; and Part 4 used the Renal symp-
toms Palliative care Outcome Scale (POS-S Renal) to
score patient symptomatology. This paper reports on
data from Parts 1 and 2.
The KDQOL-SF Version 1.3 was developed by the
RAND Corporation [28] with multinational validation for
use in both resource-rich and resource-limited countries
[29–31]. Three principal domains are assessed in the meas-
urement of QOL and presented as composite summary
scores: Kidney Disease Composite Summary (KDCS), Phys-
ical Composite Summary (PCS) and Mental Composite
Summary (MCS). These are further subdivided into 19 sub-
domains, each comprised of a number of items namely:
 KDCS: Symptom burden − 12 items; Kidney disease
effects on daily life − 8 items; Kidney disease burden
− 4 items; Cognitive functioning − 4 items;
Employment − 2 items; Sexual functioning − 2 items;
Social interaction quality − 3 items; Quality of sleep
− 4 items; Social support structures − 2 items,
Support from dialysis staff − 2 items; and
Satisfaction of patient − 1 item.
 MCS; Fatigue/energy − 4 items; Social function − 2
items; Role emotional (role limitations due to emotional
functioning) -5 items; and Mental health − 3 items.
 PCS: Physical function − 10 items; Role physical
(role limitations due to physical functioning) -4
items; Pain − 2 items; and General health − 5 items.
The Hays algorithm was used to generate mean scores for
the three principal domains and their subdomains [20]. The
maximum achievable score for any one domain (principal or
subdomain), representing the best quality of life, is 100.
As part of this study, the KDQOL-SF tool was
translated into Luganda, the most common Ugandan
language used in and around Kampala, and adapted for
the Ugandan context [26]. Guidelines provided by RAND
Health Care were followed during tool translation [32].
Statistical analysis
Questionnaire data were entered into EpiData Ver. 3.1
[33] and analysed in STATA version 12.0 [34] after final
data cleaning. Descriptive statistics were used for sum-
marizing the data on sample composition and character-
istics. QOL scores were calculated for each participant
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following Hays algorithm [28] and then overall scores
computed as means and standard deviations. With 100
representing the best QOL score, patient scores were
categorised into high (≥50) and low (< 50) for the scale
as a whole and for each of the three principal domains
(physical, mental and kidney disease specific). Fifty was
chosen as a cut-off having been used in QOL studies
worldwide [35]. For the Physical health and Mental
health principal domains, a score of 50 is standardized
to the general public [36, 37].
Continuous variables were reported as either mean ±
standard deviation (SD) or median and interquartile range
(IQR) based on their distribution. Categorical variables
were analyzed using Chi-square test or the contingency
coefficient, as appropriate. For the quantitative variables,
after checking normality with the Kolmogorov-Smirnov
test, the T-Student test or Mann-Whitney were used to
compare the scores between hemodialysis (HD) and Non-
hemodialysis, as suitable. Simple and multiple linear
regression analyses were performed to identify the predic-
tors of KDCS, PCS, and MCS. P-values of < 0.05 were
considered statistically significant [38]. The variables with
p < 0.20 at univariate analysis were selected and included
in the multivariate linear regression model using backward
variable selection method.
Results
Demographic and clinical data
One thousand five hundred ninety-four patients were
screened from the renal outpatients’ clinic, renal inpatients’
ward and the HD unit from January 2019 to November
2019. Three hundred and sixty four (364) patients were en-
rolled into the study. The majority of patients were ineli-
gible to participate because they had chronic kidney disease
stages I to IV (859/1594) or acute kidney injury (272/1594).
Among patients with chronic kidney disease stage V, the
commonest reason for ineligibility was severe morbidity
(26/410) and language barrier (11/410). Of the recruited
patients, 124 were on HD while 240 patients were on non-
HD management (Fig. 1). As shown in Table 1, 62% of par-
ticipants were aged < 50 years; the majority were male
(60.2%), married (62.3%), with a family size of ≤5 (56.3%)
and belonging to the Christian faith (72.7%). An over-
whelming majority reported that they were employed
(92%), although only 45.9% reported that their jobs were
their main source of income and 27.7% that they were the
breadwinners in the family. Hypertension was the com-
monest comorbidity (80.8%) followed by Diabetes (27.5%).
Education level and the kidney disease principal domain
scores were the only statistically significant difference be-
tween the two patient management groups. The HD group
had higher education levels compared to the non-HD
group (p-value < 0.001) and higher kidney disease principal
domain scores (p-value < 0.001). Overall QOL scores,
however, were not significantly different between the two
groups (p-value 0.102).
Quality of life score
94.3% of patients had an overall mean QOL score of less
than 50 (maximum 100): median of 42.2 (38,8, 44.5) for
Fig. 1 Patient Recruitment Flow chart
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Table 1 Characteristics of End Stage Renal Disease Patients in a tertiary hospital in Uganda
Characteristics Non-Haemodialysis Haemodialysis Overall Total
(N = 364)
p-value
n = 240 % n = 124 %
Gender 0.134
Female 98 42.6 39 34.2 137 39.8
Male 132 57.4 75 65.8 207 60.2
Age 0.294
18–50 152 63.9 71 58.2 223 62.0
≥ 50 86 36.1 51 41.8 137 38.0
Median (IQR) 45 (34,56) 48 (36,58) 46 (35,58)
Marital status 0.196
Married 138 57.5 80 64.5 218 62.3
Single 102 42.5 44 35.5 146 37.7
Education level <.001*
None 26 10.8 13 10.5 39 10.7
Primary 78 32.5 19 15.3 97 26.6
Secondary 99 41.3 46 37.1 145 39.8
Post-Secondary 37 15.4 46 37.1 83 22.8
Family size 0.346
≤ 5 128 58.2 58 52.7 186 56.3
> 5 92 41.8 52 47.3 144 43.6
Religion 0.211
None/Others 15 6.3 13 10.5 28 7.6
Muslim 42 17.5 29 23.4 71 19.5
Catholic 97 40.4 43 34.7 140 38.4
Protestant 86 35.8 39 31.5 125 34.3
Occupation 0.720
Employed 220 91.7 115 92.7 335 92.0
Unemployed 20 8.3 9 7.3 29 8.0
Main source of income 0.138
Donations 69 28.7 36 29.0 105 28.8
My job 103 42.9 64 51.6 167 45.9
Savings/others 68 28.3 24 19.4 92 25.3
Bread winner 0.182
No 168 70.0 95 76.6 263 72.3
Yes 72 30.0 29 23.4 101 27.7
Hypertension 0.101
No 52 21.7 18 14.5 70 19.2
Yes 188 78.3 106 85.5 294 80.8
Stroke 0.146
No 235 97.9 118 95.2 353 97.0
Yes 5 2.1 6 4.8 11 3.0
Diabetes 0.609
No 172 71.7 92 74.2 264 72.5
Yes 68 28.3 32 25.8 100 27.5
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the HD group and 40.9 (35.9, 43.9) for the non-HD, with
the difference between the two groups not statistically
significant (Table 1)
Details of the domain and subdomain scores are
shown in Table 2. There was no statistically significant
difference between the non-HD and HD groups in the
three principal domain scores, which were, respectively:
PCS of 34.23 vs 33.14, MCS of 38.02 vs 38.01 and KDCS
of 48.52 vs 53.04. Overall, Social support at 74.24 (non-
HD) and 78.36 (HD) was the highest scoring subdomain
for both patient management groups. In contrast,
patients identified major role limitations due to both
physical health (5.93 non-HD and 0.21 HD) and emo-
tional health (6.07 non- HD and 0.55 HD). These were
Table 1 Characteristics of End Stage Renal Disease Patients in a tertiary hospital in Uganda (Continued)
Characteristics Non-Haemodialysis Haemodialysis Overall Total
(N = 364)
p-value
n = 240 % n = 124 %
KDCs <.001*
≤ 50 170 70.8 53 42.7 223 61.3
> 50 70 29.2 71 57.3 141 38.7
Median (IQR) 49.1 (38.7, 57.6) 54.7 (48.5, 60.4) 51.1 (41.3, 58.9)
Overall health score 0.102
≤ 50 208 92.9 107 97.3 315 94.3
> 50 16 7.1 3 2.7 19 5.7
Median (IQR) 40.9 (35.9, 43.9) 42.2 (38.8, 44.5) 41.3 (37.1, 44.2)
KDCS Kidney disease composite summary, PCS Physical composite summary, MCS Mental composite summary *Statistically significant Variables (P-value < 0.05)
Table 2 Quality of Life Domain Scores for Patients with End Stage Renal Disease in a tertiary hospital in Uganda
Parameter Non-Haemodialysis Haemodialysis p-value
Mean SD Mean SD
Kidney disease-specific domains
Symptom/problem list [12] 34.48 36.36 65.82 24.23 1.0000
Effects of kidney disease [8] 47.85 24.92 47.15 22.54 0.3967
Burden of kidney disease [4] 25.57 17.92 19.25 15.32 0.0005**
Work status [2] 31.88 26.56 45.56 22.99 1.0000
Cognitive function [3] 67.39 22.98 63.66 22.47 0.0699
Quality of social interaction [3] 59.58 16.90 61.88 16.90 0.8902
Sleep [4] 47.17 19.51 42.66 16.78 0.0147**
Social support [2] 74.24 29.12 78.36 29.13 0.8994
KDCS 48.52 13.59 53.04 12.16 0.9990
SF-36
Physical functioning [10] 29.02 26.42 18.89 22.27 0.0002**
Role limitations--physical [4] 5.93 22.75 0.21 2.29 0.0033**
Pain [2] 66.71 27.11 72.94 27.36 0.9791
General health [5] 37.95 15.23 39.66 37.13 0.8453
Emotional well-being [5] 50.82 11.33 52.85 10.37 0.9483
Role limitations--emotional [3] 6.07 22.71 0.55 4.29 0.0044**
Social function [2] 61.56 22.79 59.21 24.95 0.1927
Energy/fatigue [4] 47.93 13.46 50.13 12.51 0.9296
PCS 34.23 7.63 33.14 6.02 0.0957
MCS 38.02 5.80 38.01 4.77 0.4866
OVERALL HEALTH SCORE 40.43 6.20 41.71 4.42 0.9733
**significant at p < .05; KDCS Kidney disease composite summary, SF Short Form health survey, MCS Mental composite summary, PCS Physical composite summary;
Maximum score = 100 per domain, SD Standard Deviation Numbers in brackets represent number of items in each subdomain
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the lowest scoring items, particularly in the hemodialysis
group.
Statistically significant differences between the scores
of the two groups were however noted in five subdo-
mains (Table 2). In the kidney disease principal domain,
these were Burden of kidney disease (25.57 non-HD vs
19.25 HD) (p-value: 0.0005) and Sleep (47.17 vs 42.66)
(p-value: 0.0147). In the Physical health principal do-
main, these were Physical functioning (29.02 vs 18.38)
(p-value: 0.0002) and Role limitations due to physical
function (5.93 vs 0.21) (p-value: 0.0033). In the Mental
health principal domain, this was Role limitations due to
emotional functioning (6.07 vs 0.55) (p-value: 0.0044). In
all five subdomains the non-HD group had higher scores
reflecting better quality of life.
In univariate analysis (Table 3), we found three factors
to be significantly associated with low QOL scores,
namely: main source of income (p0.024, CI (− 7.90, −
0.57)), breadwinner status (p < 0.001, CI (− 9.76, − 3.80))
and management type (p0.0033, CI (− 3.52, − 0.15)). All
three factors were significant in the kidney disease or
physical health principal domains, with none signifi-
cantly associated with overall QOL scores or the mental
health principal domain. Hemodialysis management type
demonstrated a tendency to higher QOL scores in the
kidney disease principal domain only, while savings as
the main source of income and not being a breadwinner
were associated with lower QOL scores in the kidney
disease and physical health principal domains.
In multivariate analysis (Table 4), main source of income,
breadwinner status and management type were again iden-
tified to contribute significantly to participants’ QOL.
Hemodialysis management (p0.032, CI (0.29, 6.32)) and the
patient’s job being their main source of income (p0.026, CI
(0.27, 4.29)) were associated with higher QOL scores in, re-
spectively, the kidney disease and physical health principal
domains, while not being a breadwinner was associated
with lower scores (p0.001, CI (− 9.48, − 3.02)) in the kidney
disease principal domain.
Discussion
We measured the health-related quality of life of
patients with end stage renal disease in Uganda, using
the KDQOL-SF Ver 1.3, and compared the scores of
patients on hemodialysis to those on non-hemodialysis
management. We also explored factors associated with
quality of life scores in both management groups. The
scores of our sample of Ugandan ESRD patients were
lower than the scores of any group of ESRD patients
reported in the literature we have accessed, with no
statistically significant difference between the two
management groups. Breadwinner status, source of
income and management type were the only factors
significantly associated with QOL scores.
Patient characteristics in context
The mean age, 45.9 years, of our study population was
comparable to that in other studies from developing
countries such as India (42, +/− 13.4) [35], Ghana (43,
+/− 17.8) [39] and Nigeria (42, +/− 15.43) [40] but differ-
ent from that in studies from developed countries such
as the United Kingdom (82, +/_6) [25], USA (62, +/_14)
[3] and the Netherlands (> 70) [41]. This reflects the
varying aetiologies of kidney disease in different settings
but also demonstrates that, in the developing world, the
impact of kidney disease is borne by the most economic-
ally productive age groups, with adverse consequences
for development. Additionally, the younger patient age –
indicating better physiological capability and, therefore,
a higher likelihood for better long term outcomes – ends
up losing its relative advantages due to seriously limited
resources to cover healthcare related expenditure.
Males (at 60.2%) were the predominant sex in our study,
a recurrent pattern in the majority of studies from both
developed and developing counties such as Ghana (64.5%)
[39], USA (59%) [3] and India (68.1%) [35]. In our study, it
matched our experience-based observations of the health
seeking behaviours of Mulago Hospital patients. As a ter-
tiary care centre, Mulago Hospital is a setting of expensive
care. Women may prefer to avoid referral due to health-
care related factors (e.g. distance from their family and
support systems and lack of personal financial capacity to
cover healthcare related expenditure) or patient related
factors (e.g. low educational level, preference for alterna-
tive medicine and concerns about voicing their pain and
suffering) [42]. Similar findings have been reported in a
Nigerian study where 59.04% of patients accepted
hemodialysis because they could afford it, with only
20.48% of these patients being female [22]. We also found
that 72% of participants were not the breadwinners in the
family and 51.64% of these were males, implying that
many females are left with the burden of caring for the pa-
tient and providing for large families (41%, > 5 individuals)
because of loss of income from the spouse. This contrib-
utes to the rising trend of household financial distress
associated with chronic disease in families [21, 22, 43].
Patients on HD were significantly more likely to have a
higher educational level compared to patients on non-HD
management. This is a reflection of the inequity in access
to renal replacement therapies based on socioeconomic
status that has been described in various studies [44–46].
Developed settings have broader hemodialysis access in
comparison to developing settings [46] and educated
patients are more likely to afford and sustain treatment,
especially where no or limited health insurance exists [45].
Health related quality of life findings in context
Our findings showed that overall mean HRQOL for pa-
tients with ESRD is low, with 94.3% participants scoring
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less than 50 (out of 100) and only 19 participants scoring
over 50. The scores obtained in this study were lower
than any previously reported KDQOL-SF scores, both in
developed and developing world settings. An Indian
study reported physical composite scores of 31.76 (in
HD patients) and 30.36 (in non-HD patients), mental
composite scores of 42.24 (HD) and 42.39 (non-HD),
and kidney disease composite scores of 60.45 (HD) and
60.51 (non-HD) [35]. Of these, only the physical com-
posite scores were lower than those in our study, namely
of 33.14 (HD) and 34.23 (non-HD). Moreover, the kid-
ney disease composite scores we recorded were 7 to 12
points lower than in the Indian sample, namely of 53.04
(HD) and 48.52 (non-HD). The difference in the mental
Table 3 Impact of social and clinical parameters on Quality of life domain scores
Parameter KDCS PCS MCS
Beta p-value 95% CI Beta p-value 95% CI Beta p-value 95% CI
Gender
Male − 0.476 0.743 [− 3.33, 2.37] − 0.869 0.283 [− 2.46, 0.72] − 0.559 0.377 [− 1.81, 0.69]
Age
30–49 3.142 0.123 [− 0.86, 7.14] 0.849 0.465 [− 1.44, 3.13] 1.588 0.076 [− 0.16, 3.34]
50–70 2.042 0.339 [− 2.15, 6.23] 0.213 0.861 [− 2.19, 2.62] 1.387 0.140 [− 0.46, 3.23]
> 70 3.459 0.341 [− 3.68, 10.60] −1.115 0.595 [−5.24, 3.01] − 1.107 0.492 [− 4.27, 2.05]
Marital status
Not Married −1.821 0.200 [−4.61, 0.97] −0.705 0.378 [−2.28, 0.87] − 0.290 0.636 [−1.49, 0.91]
Education level
Primary 2.108 0.402 [−2.83, 7.05] 1.807 0.201 [−0.97, 4.58] 0.448 0.679 [−1.68, 2.58]
Secondary 0.867 0.717 [−3.83, 5.57] 1.646 0.224 [−1.01, 4.30] 0.391 0.706 [−1.65, 2.43]
Post-Secondary 4.404 0.088 [−0.66, 9.46] 2.049 0.156 [−0.78, 4.88] 0.710 0.521 [−1.46, 2.89]
Family size
3–5 1.657 0.419 [−2.37, 5.68] 1.034 0.367 [−1.21, 3.28] −0.369 0.673 [−2.09, 1.35]
6 + 0.994 0.634 [−3.10, 5.09] 0.684 0.558 [−1.61, 2.98] −1.338 0.134 [−3.09, 0.41]
Religion
Muslim −0.274 0.927 [−6.12, 5.58] −1.863 0.277 [−5.23, 1.50] −1.374 0.297 [−3.96, 1.22]
Catholic 0.366 0.895 [−5.06, 5.79] −1.692 0.285 [−4.80, 1.42] −1.126 0.355 [−3.52, 1.27]
Protestant −0.577 0.836 [−6.01, 4.90] 0.001 0.999 [−3.15, 3.16] −1.605 0.194 [−4.03, 0.82]
Occupation
Unemployed −3.941 0.125 [−8.99, 1.11] 2.237 0.148 [−0.79, 5.27] 0.703 0.553 [−1.63, 3.03]
Main source of income
My job 2.322 0.154 [−0.88, 5.52] 1.470 0.119 [−0.38, 3.32] 0.592 0.416 [−0.84, 2.02]
Savings/others −4.235 0.024* [−7.90, −0.57] −1.042 0.322 [−3.11, 1.02] −0.380 0.640 [−1.98, 1.22]
Bread winner
No −6.784 <.001* [−9.76, −3.80] −1.841 0.033* [−3.52, −0.15] −1.184 0.073 [−2.48, 0.11]
Hypertension
No 0.819 0.643 [− 2.65, 4.29] −0.731 0.458 [−2.67, 1.20] 0.784 0.298 [−0.69, 2.26]
Stroke
No 0.464 0.909 [−7.54, 8.47] −1.054 0.681 [−6.09, 3.99] − 1.464 0.456 [−5.32, 2.39]
Diabetes
No 0.308 0.844 [−2.76, 3.38] 1.229 0.157 [−0.47, 2.93] −0.957 0.150 [−2.26, 0.348]
Cancer
No −3.641 0.586 [−16.79, 9.50] −0.777 0.829 [−7.87, 6.31] 1.613 0.559 [−3.81, 7.04]
Type of patients
Haemodialysis 4.448 0.003* [1.50, 7.39] −0.897 0.285 [−2.55, 0.75] 0.069 0.916 [−1.22, 1.36]
*significant at p < .05; KDCS Kidney disease composite summary, SF Short Form health survey, MCS Mental composite summary, PCS Physical composite summary
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composite scores was more moderate, with figures from
the current study of 38.01 (HD) and 38.02 (non-HD).
Furthermore, a systematic review of studies on QOL of
hemodialysis and peritoneal dialysis (PD) patients from
seven middle or high income countries (South Africa,
Saudi Arabia, Ireland, Korea, Brazil, Singapore and USA)
estimated higher pooled QOL scores: physical composite
scores of 39.50 (PD) and 40.00 (HD), mental composite
scores of 47.50 (PD) and 46.50 (HD) and an overall
health related quality of life score of 63.00 for both PD
and HD [47].
It can be argued that the uniquely low quality of life
scores amongst Ugandan ESRD patients result, to a sig-
nificant degree, from resource limitations, presenting as
lack of access to a plethora of support services available
in resource-rich countries, such as nutritional advice or
psychotherapy; lack of supportive institutional policies,
such as free access to Erythropoetin stimulating agents
or complimentary transportation to and from the
hemodialysis units; and, most importantly, lack of access
to kidney transplant programs.
Comparison of QOL between hemodialysis and non-
hemodialysis management groups
We found no statistically significant difference in overall
quality of life scores for the two management groups.
However, there were statistically significant differences
between the scores of the two groups in five subdo-
mains, namely: Burden of kidney disease, Sleep, Physical
functioning, Role limitations due to physical functioning
and Role limitations due to emotional functioning. In all
of these subdomains, patients on non-HD management
scored higher. A recent systematic review of four studies
comparing the QOL scores of the two group types
showed higher mental composite scores and a sustained
higher overall HRQOL for patients on non-HD as op-
posed to higher physical composite scores for patients
on HD which, however, declined over time [48]. The
study authors suggested that the coping strategies
employed by the non-HD group, such as acceptance of
the disease and adjustment to life with their disease con-
dition as well as the impending end of life, ultimately
lead to better HRQOL. Additionally, reports from devel-
oped settings indicate that HD may not provide a clear
benefit over non-HD in terms of survival and quality of
life, especially for an aging population and in the pres-
ence of extensive comorbidities [49, 50].
Our hospital has only one nutritionist for the entire
800-bed facility and no dedicated physiotherapist or
psychologist covering the renal units. Patients spend
heavily on transport and rented accommodation, espe-
cially if they live far from the hemodialysis unit. In order
to reduce expenditure, patients on hemodialysis rou-
tinely carry out only two hemodialysis sessions per week,
Table 4 Multiple linear regression analysis of factors associated with low Quality of life scores
Parameter KDCS PCS MCS
Beta p-value 95% CI Beta p-value 95% CI Beta p-value 95% CI
Gender
Male −0.119 0.938 [−3.12, 2.88] −0.735 0.400 [− 2.45, 0.98] − 0.447 0.519 [−1.81, 0.92]
Education level
Primary 0.854 0.778 [−5.11, 6.82] 2.017 0.236 [−1.32, 5.35] 1.741 0.198 [−0.91, 4.39]
Secondary −0.343 0.907 [−6.13, 5.44] 2.025 0.223 [−1.24, 5.29] 1.668 0.206 [−0.92, 4.26]
Post-Secondary 2.050 0.513 [−4.11, 8.21] 2.564 0.144 [−0.88, 6.01] 1.961 0.159 [−0.78, 4.69]
Occupation
Unemployed −4.150 0.128 [−9.49, 1.19] 1.213 0.454 [−1.97, 4.39] 0.405 0.753 [−2.12, 2.93]
Main source of income
My job 2.896 0.100 [−0.56, 6.35] 2.279 0.026* [0.27, 4.29] 0.981 0.228 [−0.62, 2.58]
Savings/others −1.199 0.542 [−5.06, 2.67] 0.093 0.933 [−2.09, 2.28] 0.128 0.885 [−1.61, 1.87]
Bread winner
No −6.253 <.001* [−9.48, −3.02] −1.678 0.070 [−3.49, 0.13] −1.023 0.164 [−2.46, 0.42]
Stroke
No 1.741 0.664 [−6.13, 9.62] −1.429 0.575 [−6.44, 3.58] −1.075 0.595 [−5.06, 2.90]
Diabetes
No 0.381 0.806 [−2.67, 3.43] 1.363 0.122 [−0.37, 3.09] −1.072 0.126 [−2.45, 0.30]
Type of patients
Haemodialysis 3.306 0.032* [0.29, 6.32] −1.193 0.176 [−2.92, 0.54] −0.157 0.822 [−1.53, 1.22]
*significant at p < .05; KDCS Kidney disease composite summary, SF Short Form health survey, MCS Mental composite summary, PCS Physical composite summary
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while international standards stipulate a minimum of
three sessions per week [51]. As a result, the clearance
of uremic toxins can be inadequate, with implications
for symptom burden and, in turn, quality of life, contrib-
uting to the minimal overall difference found between
the QOL of patients on hemodialysis and those on
non-HD. This too may contribute to the elimination
of the physical health benefit of dialysis seen in other
studies [48].
The lack of routine assessments of health-related
quality of life in our setting may be a further factor
explaining the low scores found. In the US, for
example, patients receiving hemodialysis by the
Centre for Medicare Services should be offered a
mandatory routine HRQOL assessment within four
months of dialysis initiation and thereafter annually
or as necessitated after any significant life changing
event [52]. Studies from developed settings have
shown improvements in quality of life in patients for
whom exercise regimens or programs have been
introduced into dialysis sessions, but this and other
related interventions have to be triggered by routine
assessment of baseline HRQOL [53]. Routine assess-
ment of depression is also potentially important for
achieving improvements in health-related quality of
life, as depression has been found to contribute to low
mental composite scores and, in one study, to be associated
with increased risk for death and hospitalization [54, 55].
Factors associated with QOL scores
We found only three factors to be significantly associated
with QOL scores: source of income, breadwinner status
and management type. A patient’s job being their main
source of income was associated with a tendency towards
higher QOL scores in the physical health domain.
Hemodialysis management was associated with higher
QOL scores and not being a breadwinner was associated
with lower QOL scores, both observed only in the kidney
disease principal domain. No factors were found to be sig-
nificantly associated with scores for the mental health
principal domain and/or overall QOL score.
Similarly to our findings, which suggest that a patient’s
job being their main source of income was associated
with higher QOL scores, a Taiwanese multicenter study
found that higher monthly income or health insurance
were positively associated with health-related quality of
life in hemodialysis patients [56]. Studies from Nepal
and South Africa have shown hemodialysis management
to be associated with higher QOL scores in the physical
health principal domain while we found it to be associ-
ated with higher QOL scores in the kidney disease
domain [57, 58]. This may be due to different degrees of
physical symptom alleviation achieved by adequate vs.
inadequate number of dialysis sessions.
Strengths and limitations
Our study has been the first to explore the quality of life
of end stage renal disease patients in Uganda. It used an
internationally validated and widely used instrument for
assessing HRQOL in patients with ESRD, adding cred-
ibility to its findings and offering opportunities for com-
parisons with findings from other settings. The tool was
translated into one of the local languages of Uganda, cul-
turally adapted to the local setting and validated (paper
in preparation). To our knowledge, this is also the study
with the largest participant sample assessing quality of
life in patients with ESRD in Sub-Saharan Africa. Sample
sizes in other studies ranging from 22 to 202 participants,
namely 22 in a study from Malawi [59], 106 in a study
from South Africa [60] and 202 from Ghana [12].
Findings may have limited generalizability by virtue of
being generated in a single centre. At the same time, this
is the largest renal unit in the country and part of the
national referral hospital, receiving patients from the
whole of Uganda as well as neighbouring countries, such
as the Democratic Republic of Congo, Rwanda and
South Sudan. The hospital is also serving a signifi-
cant refugee population from Ethiopia, Somalia, Burundi
and the above neighbouring countries.
We found only three variables to be statistically signifi-
cantly associated with quality of life – not being the
breadwinner, hemodialysis treatment and patient’s job as
the main source of income – but the relationship was
only limited to the kidney disease specific domain (the
former two variables) and the physical health principal
domain (the third variable). They had no significant
association with overall QOL. It is possible that the
pattern of scores we observed – too low across the
board and thus lacking variety – has precluded the iden-
tification of valid risk factors. A different tool or method
may be needed to trace risk factors in our particular
setting.
As this was a baseline study, it is also possible that
participants have not had enough time to adjust to their
clinical diagnosis. The ongoing follow-up quantitative
study and accompanying qualitative interviews will en-
able us to draw a more accurate picture of how patients
adjust to their illness, what coping strategies they
employ and, ultimately, what it is like to live with ESRD
in Uganda.
Conclusion
Patients with ESRD in Uganda are younger than in
developed countries, predominantly male, and have sig-
nificantly compromised quality of life scores compared
to those reported from other developed or developing
settings. There was no significant difference in overall
QOL scores between patients on hemodialysis in com-
parison to those on non-hemodialysis management. HD
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was positively associated with kidney disease composite
scores but does not appear to improve the overall
HRQOL of patients with ESRD in this setting. It is asso-
ciated with an increased kidney disease burden, poor
sleep, reduced physical functioning and role limitations
due to changes in physical and emotional functioning.
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